Polyethylene glycol as a solvent for diazepam: bioavailability and clinical effects after intramuscular administration, comparison of oral, intramuscular and rectal administration, and precipitation from intravenous solutions.
D000284:Administration, Oral; D000328:Adult; D001682:Biological Availability; D011232:Chemical Precipitation; D002986:Clinical Trials as Topic; D003402:Creatine Kinase / Q000097:blood; D003975:Diazepam / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D004341:Drug Evaluation; D005221:Fatigue; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D011092:Polyethylene Glycols; D012007:Rectum; D012997:Solvents; D013997:Time Factors
D012997:Solvents; D011092:Polyethylene Glycols; D003402:Creatine Kinase; D003975:Diazepam